CHEMCON.NS Stock Analysis
CH
Avoid
Based on Eyestock quantitative analysis, CHEMCON.NS`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Chemcon Speciality Chemicals Ltd. engages in the manufacture and sale of chemicals for pharmaceuticals and oilfield industries. The company is headquartered in Vadodara, Gujarat and currently employs 204 full-time employees. The company went IPO on 2020-10-01. The firm is engaged in producing pharmaceutical intermediates and oil well completion chemicals (completion fluids). The company is also engaged in manufacturing specialized chemicals, such as hexamethyl disilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC), which are used in the pharmaceuticals industry and inorganic bromides, namely zinc bromide and calcium bromide that are used as completion fluids in the oilfield industry. Its products include hexamethyl disilazane (HMDS), chloromethyl isopropyl carbonate (CMIC) and calcium bromide liquid. The firm supply its products to domestic customers and export its products to countries including United States of America, Italy, South Korea, Germany, People’s Republic of China, Japan, United Arab Emirates, Serbia, Russia, Spain, Thailand and Malaysia.